Literature DB >> 12970448

JC virus-induced changes in cellular gene expression in primary human astrocytes.

Sujatha Radhakrishnan1, Jessica Otte, Sahnila Enam, Luis Del Valle, Kamel Khalili, Jennifer Gordon.   

Abstract

Cell-type-specific transcription of the JC virus (JCV) promoter in glial cells initiates a series of events leading to viral replication in the brain and the development of the fatal demyelinating disease progressive multifocal leukoencephalopathy (PML) in patients with neurologic complications due to infection with human immunodeficiency virus type 1. Here we employed an in vitro infection of primary cultures of human astrocytes to compare the transcriptional profile of cellular genes after JCV infection by using an oligonucleotide-based microarray of 12600 genes. Transcription of nearly 355 genes was enhanced and expression of 130 genes was decreased to various degrees. Many transcripts that were increased upon JCV infection were found to encode proteins with properties that suggest their involvement in cell proliferation, including cyclin A and cyclin B1; signaling pathways, such as transforming growth factor beta receptor 1, platelet-derived growth factor receptor and fibroblast growth factor family receptor; and other regulatory events, such as inflammatory responses, including cyclo-oxygenase-2 (Cox-2). Microarray-based data for several cell cycle-regulatory genes were further examined by using Western blot analysis of in vitro infected astrocytes harvested early and late during the infection. Results demonstrate that protein levels of all upregulated genes were found to increase at some point during the infection time course. In parallel, immunohistochemical assessment of cell cycle proteins, including cyclins A, B1, E, and Cdk2, showed positive staining of astrocytes within PML lesions of brain tissue from patients with neuro-AIDS. Microarray analysis was found to be a useful predictor of gene expression in infected cells; however, it may not directly correlate with protein levels during infection with JCV.

Entities:  

Mesh:

Year:  2003        PMID: 12970448      PMCID: PMC228539          DOI: 10.1128/jvi.77.19.10638-10644.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

Review 1.  Human immunodeficiency virus: infection of the nervous system.

Authors:  C A Wiley; J A Nelson
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

2.  Comparison of infectious JC virus DNAs cloned from human brain.

Authors:  B W Grinnell; B L Padgett; D L Walker
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

3.  Progressive multifocal leukoencephalopathy: clinical and radiographic features.

Authors:  L B Krupp; R B Lipton; M L Swerdlow; N E Leeds; J Llena
Journal:  Ann Neurol       Date:  1985-04       Impact factor: 10.422

4.  Human immunodeficiency virus (HIV) and JC virus in acquired immune deficiency syndrome (AIDS) patients with progressive multifocal leukoencephalopathy.

Authors:  C A Wiley; M Grafe; C Kennedy; J A Nelson
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

5.  Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland.

Authors:  W Lang; J Miklossy; J P Deruaz; G P Pizzolato; A Probst; T Schaffner; E Gessaga; P Kleihues
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Extension of JC virus host range to monkey cells by insertion of a simian virus 40 enhancer into the JC virus regulatory region.

Authors:  D A Vacante; R Traub; E O Major
Journal:  Virology       Date:  1989-06       Impact factor: 3.616

Review 7.  Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases.

Authors:  J R Berger; B Kaszovitz; M J Post; G Dickinson
Journal:  Ann Intern Med       Date:  1987-07       Impact factor: 25.391

8.  Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients.

Authors:  W D Snider; D M Simpson; S Nielsen; J W Gold; C E Metroka; J B Posner
Journal:  Ann Neurol       Date:  1983-10       Impact factor: 10.422

9.  Prevalence rate and age of acquisition of antibodies against JC virus and BK virus in human sera.

Authors:  F Taguchi; J Kajioka; T Miyamura
Journal:  Microbiol Immunol       Date:  1982       Impact factor: 1.955

Review 10.  The neuropathology of AIDS. UCLA experience and review.

Authors:  K H Anders; W F Guerra; U Tomiyasu; M A Verity; H V Vinters
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307

View more
  40 in total

1.  Analysis of JC virus DNA replication using a quantitative and high-throughput assay.

Authors:  Jong Shin; Paul J Phelan; Panharith Chhum; Nazym Bashkenova; Sung Yim; Robert Parker; David Gagnon; Ole Gjoerup; Jacques Archambault; Peter A Bullock
Journal:  Virology       Date:  2014-08-24       Impact factor: 3.616

2.  Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy.

Authors:  Hassen S Wollebo; Mahmut Safak; Luis Del Valle; Kamel Khalili; Martyn K White
Journal:  J Neuroimmunol       Date:  2010-12-24       Impact factor: 3.478

3.  Alterations of DNA damage repair pathways resulting from JCV infection.

Authors:  Armine Darbinyan; Martyn K White; Selma Akan; Sujatha Radhakrishnan; Luis Del Valle; Shohreh Amini; Kamel Khalili
Journal:  Virology       Date:  2007-03-21       Impact factor: 3.616

Review 4.  Animal Models for Progressive Multifocal Leukoencephalopathy.

Authors:  Martyn K White; Jennifer Gordon; Joseph R Berger; Kamel Khalili
Journal:  J Cell Physiol       Date:  2015-12       Impact factor: 6.384

5.  Merkel Cell Polyomavirus Downregulates N-myc Downstream-Regulated Gene 1, Leading to Cellular Proliferation and Migration.

Authors:  Purnima Gupta; Naveed Shahzad; Alexis Harold; Masahiro Shuda; Assunta Venuti; Maria Carmen Romero-Medina; Laura Pacini; Lise Brault; Alexis Robitaille; Valerio Taverniti; Hector Hernandez-Vargas; Geoffroy Durand; Florence Le Calvez-Kelm; Tarik Gheit; Rosita Accardi; Massimo Tommasino
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

6.  Generation and characterization of JCV permissive hybrid cell lines.

Authors:  Ilker K Sariyer; Mahmut Safak; Jennifer Gordon; Kamel Khalili
Journal:  J Virol Methods       Date:  2009-03-04       Impact factor: 2.014

7.  Evidence for modulation of BAG3 by polyomavirus JC early protein.

Authors:  Anna Basile; Nune Darbinian; Rafal Kaminski; Martyn K White; Antonio Gentilella; Maria Caterina Turco; Kamel Khalili
Journal:  J Gen Virol       Date:  2009-03-12       Impact factor: 3.891

8.  Global effects of BKV infection on gene expression in human primary kidney epithelial cells.

Authors:  Johanna R Abend; Jonathan A Low; Michael J Imperiale
Journal:  Virology       Date:  2009-11-28       Impact factor: 3.616

9.  Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter.

Authors:  Luca Romagnoli; Ilker K Sariyer; Jacqueline Tung; Mariha Feliciano; Bassel E Sawaya; Luis Del Valle; Pasquale Ferrante; Kamel Khalili; Mahmut Safak; Martyn K White
Journal:  Virology       Date:  2008-03-18       Impact factor: 3.616

10.  Intracellular approach for blocking JC virus gene expression by using RNA interference during viral infection.

Authors:  Sujatha Radhakrishnan; Jennifer Gordon; Luis Del Valle; Jianqi Cui; Kamel Khalili
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.